Dr. Shirley Fred Hartley, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 112 W Pasadena Blvd, Deer Park, TX 77536 Phone: 281-479-5311 Fax: 281-479-0748 |
S. F. Hartley, D.p.m., P.c. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 112 W Pasadena Blvd, Deer Park, TX 77536 Phone: 281-479-5311 Fax: 281-479-0748 |
Foot And Ankle Specialists Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 112 W Pasadena Blvd, Deer Park, TX 77536 Phone: 281-479-5311 Fax: 281-479-0748 |
Mohammed A Farooqui, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 112 W Pasadena Blvd, Deer Park, TX 77536 Phone: 281-479-5311 Fax: 281-479-0748 |
News Archive
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
The unofficial "kickoff" to summer is only a few weeks away. While we hope everyone has fun this coming Memorial Day weekend, the nation's emergency physicians want everyone to stay safe and out of the ER.
Oscine Therapeutics, a new biotechnology company based on discoveries made and developed at the University of Rochester Medical Center has received a significant multi-year investment to support both research and development of cell-based therapies for neurological disorders.
A group led by Dr. Massimo Loda at the Dana Farber Cancer Institute, Boston, MA has generated a preclinical model of human prostate cancer that mimics the genetic and growth behavior of primary tumors. Their report can be found in the April 2010 issue of the American Journal of Pathology.
› Verified 3 days ago